Amdocs Limited (DOX) SEC Filings & Earnings Calls
EquiReason read 13 Amdocs Limited SEC filings in the last 12 months. Latest: 6-K on 2026-08-18 — Q3 2026 revenue $1.175B (+2.7% YoY), net income $63.2M (-59% YoY), EPS $0.59 (-58% YoY). Operating income fell to $104.5M from $202.5M. Restructuring charges of $106.4M impacted re.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 6.8B
- P/E TTM
- 12.4
- Dividend yield
- 3.3%
- 52-week
- —
- Next earnings
- 17 Nov, in 24 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
18 Aug 20266-KQ3 2026 revenue $1.175B (+2.7% YoY), net income $63.2M (-59% YoY), EPS $0.59 (-58% YoY). Operating income fell to $104.5M from $202.5M. Restructuring charges of $106.4M impacted results.open
Figures in the filing · each found in the filing text
| Revenue · Q3-2026 | $1.17B | +3% y/y |
| Net income attributable to Amdocs · Q3-2026 | $62M | -60% y/y |
| Diluted EPS · Q3-2026 | $0.59 | -58% y/y |
| Operating income · Q3-2026 | $105M | -48% y/y |
| Restructuring charges · Q3-2026 | $106M | |
| Cash dividend per share · Q3-2026 | $0.57 | +8% y/y |
Risks flagged
Large restructuring charge indicates operational challenges or strategic shift.
“Restructuring charges $106.4 million in Q3 2026 vs $0 in prior year.”
6 Aug 20266-KRevenue $1.18B (+3% y/y); Managed services revenue $791M (+2% y/y); Non-GAAP diluted EPS $1.84; Guidance: FY revenue growth 3.2-4.0% as reported; free cash flow $710-730Mopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2026 | $1.18B | +3% y/y |
| Managed services revenue · Managed services · Q3-2026 | $791M | +3% y/y |
| Non-GAAP diluted EPS · Q3-2026 | $1.84 | |
| Free cash flow · Q3-2026 | $172M | |
| Twelve-month backlog · Q3-2026 | $4.26B | +3% y/y |
| Share repurchases · Q3-2026 | $143M |
Guidance
FY revenue growth 3.2-4.0% as reported; free cash flow $710-730M
Solid quarter; guidance reaffirmed; margin expansion; large deal win supports growth.
Risks flagged
Restructuring charges impacting GAAP earnings; macroeconomic uncertainty.
“GAAP operating income includes a restructuring charge of $106 million; monitoring macroeconomic developments.”
26 May 20266-KRevenue $1.17B (+4% y/y); Net income $139M (-15% y/y); Diluted EPS $1.28 (-12% y/y)open
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $1.17B | +4% y/y |
| Net income · Q2-2026 | $139M | -15% y/y |
| Diluted EPS · Q2-2026 | $1.28 | -12% y/y |
Risks flagged
Restructuring charges and margin pressure
“Restructuring charges $10.4M in Q2; operating margin down from 17.5% to 15.6%”
14 May 20266-KRevenue $1.17B (+4% y/y); Non-GAAP diluted EPS $1.78; GAAP diluted EPS $1.28; Guidance: Fiscal 2026 revenue growth outlook of 2.6%-4.6% YoY as reported; constant currency range tightened to 2.0%-4.0%open
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $1.17B | +4% y/y |
| Non-GAAP diluted EPS · Q2-2026 | $1.78 | |
| GAAP diluted EPS · Q2-2026 | $1.28 | |
| Twelve-month backlog · Q2-2026 | $4.28B | +3% y/y |
| Free cash flow · Q2-2026 | $80M | |
| Managed services revenue · Q2-2026 | $759M | +2% y/y |
Guidance
Fiscal 2026 revenue growth outlook of 2.6%-4.6% YoY as reported; constant currency range tightened to 2.0%-4.0%
Reiterated midpoint of fiscal 2026 revenue growth outlook in constant currency; tightened range. Free cash flow outlook reaffirmed.
Risks flagged
Macroeconomic uncertainty and customer spending behavior could impact future performance.
“Management notes they are closely monitoring macroeconomic developments and customer spending behavior.”
23 Mar 20266-KAmdocs announced retirement of CEO Shuky Sheffer from the Board and appointment of Shimie Hortig as new Board member, effective with his CEO role.open
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $4.53B |
Risks flagged
Leadership transition risk; CEO retirement may signal strategic shift
“Shuky Sheffer retired as President and CEO and from Board”
17 Feb 20266-KAmdocs reported Q1 FY2026 revenue of $1,155.9M (vs $1,110.1M YoY) and net income of $158.5M (vs $151.9M YoY), beating prior-year results. EPS diluted $1.45 vs $1.33 YoY.open
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $1.16B | +4% y/y |
| Net income attributable to Amdocs Limited · Q1-2026 | $158M | +4% y/y |
| Diluted earnings per share · Q1-2026 | $1.45 | +9% y/y |
| Cash dividends declared per ordinary share · Q1-2026 | $0.53 | +10% y/y |
| Operating income · Q1-2026 | $207M | +4% y/y |
Risks flagged
Restructuring charges increased YoY, indicating ongoing cost optimization.
“Restructuring charges $11,301 thousand vs $6,783 thousand prior year.”
Share repurchase activity reduced outstanding shares, supporting EPS growth.
“Repurchase of shares $146,168 thousand during the quarter.”
4 Feb 20266-KAmdocs Q1 FY2026: Revenue $1.156B (+4.1% YoY), above guidance midpoint. Non-GAAP EPS $1.81 above guidance. Backlog $4.25B (+2.7% YoY). Reiterates FY2026 revenue growth 1-5% CC.open
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $1.16B | +4% y/y |
| Non-GAAP diluted EPS · Q1-2026 | $1.81 | |
| GAAP diluted EPS · Q1-2026 | $1.45 | |
| Twelve-month backlog · Q1-2026 | $4.25B | +3% y/y |
| Free cash flow · Q1-2026 | $188M | |
| Managed services revenue · Managed Services · Q1-2026 | $746M | +2% y/y |
| Europe revenue · Europe · Q1-2026 | $182M | +17% y/y |
| Share repurchases · Q1-2026 | $146M | |
| Non-GAAP operating margin · Q1-2026 | 21.6% | |
| GAAP operating margin · Q1-2026 | 17.9% |
Guidance
FY2026 revenue growth 1.0%-5.0% constant currency; free cash flow $710M-$730M
Reiterates FY2026 revenue growth outlook and free cash flow guidance; margin expansion and backlog strength support positive outlook.
Risks flagged
Macroeconomic uncertainty may impact customer spending.
“We continue to monitor our customers' demand and spending behavior within the global macroeconomic environment.” · word for word
Foreign currency movements negatively impacted revenue by ~$3M vs guidance.
“Unfavorable foreign currency movements of roughly $3 million compared to our guidance assumptions” · word for word
4 Feb 20266-KCEO Shuky Sheffer retiring; Shimie Hortig to succeed effective March 31, 2026. Planned transition, no financial impact disclosed.open
Risks flagged
CEO transition could cause short-term uncertainty, but planned succession mitigates risk.
“Planned retirement with internal successor; Board expresses full confidence.”
30 Jan 20266-KAmdocs Limited reports results of 2026 Annual General Meeting. All 10 director nominees elected; shareholders approved ESPP amendment, dividend increase to $0.569/share, financial statements, and auditor ratification.open
Figures in the filing · each found in the filing text
| Dividend per share (new rate) | $0.57 | +8% y/y |
| ESPP share increase | 2,200,000 |
15 Dec 202520-FAmdocs reported FY2025 results with revenue down 9.4% due to phase-out, but operating margin expanded to 16.1% and EPS grew 18.8%.earningsopen
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $4.53B | -9% y/y |
| Net income attributable to Amdocs Limited · FY2025 | $565M | +15% y/y |
| Diluted earnings per share · FY2025 | $5.05 | +19% y/y |
| Operating income · FY2025 | $732M | +16% y/y |
| Managed services revenue · FY2025 | $3.00B | +3% y/y |
| Capital expenditures · FY2025 | $83M | +15% y/y |
Risks flagged
Customer concentration
“Historically, AT&T has been our largest customer, accounting for 25.9% and 24.5% of our revenue in fiscal years 2025 and 2024, respectively.” · word for word
Phase-out execution risk
“we decided to phase out several low-margin, non-core business activities... These activities, which generated revenue of approximately $600 million in fiscal year 2024” · word for word
12 Nov 20256-KAmdocs reports Q4 FY2025 revenue of $1.15B (above guidance midpoint), non-GAAP EPS $1.83, 12-month backlog $4.19B (+3.2% YoY), initiates FY2026 revenue growth outlook of 1.7%-5.7% as reported, and increases dividend by 8%.open
Figures in the filing · each found in the filing text
| Revenue · Q4-2025 | $1.15B | -9% y/y |
| Non-GAAP diluted EPS · Q4-2025 | $1.83 | |
| GAAP diluted EPS · Q4-2025 | $0.88 | |
| Revenue · FY2025 | $4.53B | -9% y/y |
| Non-GAAP diluted EPS · FY2025 | $6.99 | +9% y/y |
| GAAP diluted EPS · FY2025 | $5.05 | +19% y/y |
| Free cash flow · FY2025 | $645M | |
| Twelve-month backlog · Q4-2025 | $4.19B | +3% y/y |
| Managed services revenue · FY2025 | $3.00B | |
| Share repurchases · FY2025 | $551M |
Guidance
FY2026 revenue growth 1.7%-5.7% YoY as reported; 1.0%-5.0% YoY constant currency
Initiates FY2026 revenue growth guidance of 1.7%-5.7% YoY as reported; backlog up 3.2% YoY; dividend increased 8%.
Amdocs Limited — questions
- What did Amdocs Limited file recently?
- 13 SEC filings in the last 12 months. Latest: 6-K on 2026-08-18 — Q3 2026 revenue $1.175B (+2.7% YoY), net income $63.2M (-59% YoY), EPS $0.59 (-58% YoY). Operating income fell to $104.5M from $202.5M. Restructuring charges of $106.4M impacted results.
Every figure on this page comes from Amdocs Limited's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.